194 related articles for article (PubMed ID: 8956326)
1. Human dipeptide transporter, hPEPT1, stably transfected into Chinese hamster ovary cells.
Covitz KM; Amidon GL; Sadée W
Pharm Res; 1996 Nov; 13(11):1631-4. PubMed ID: 8956326
[TBL] [Abstract][Full Text] [Related]
2. Construction, identification and application of HeLa cells stably transfected with human PEPT1 and PEPT2.
Guo X; Meng Q; Liu Q; Wang C; Sun H; Kaku T; Liu K
Peptides; 2012 Apr; 34(2):395-403. PubMed ID: 22369721
[TBL] [Abstract][Full Text] [Related]
3. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
[TBL] [Abstract][Full Text] [Related]
4. Characterization and regulation of a cloned ovine gastrointestinal peptide transporter (oPepT1) expressed in a mammalian cell line.
Chen H; Pan YX; Wong EA; Webb KE
J Nutr; 2002 Jan; 132(1):38-42. PubMed ID: 11773505
[TBL] [Abstract][Full Text] [Related]
5. CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs.
Han HK; Rhie JK; Oh DM; Saito G; Hsu CP; Stewart BH; Amidon GL
J Pharm Sci; 1999 Mar; 88(3):347-50. PubMed ID: 10052994
[TBL] [Abstract][Full Text] [Related]
6. The extracellular pH dependency of transport activity by human oligopeptide transporter 1 (hPEPT1) expressed stably in Chinese hamster ovary (CHO) cells: a reason for the bell-shaped activity versus pH.
Fujisawa Y; Tateoka R; Nara T; Kamo N; Taira T; Miyauchi S
Biol Pharm Bull; 2006 May; 29(5):997-1005. PubMed ID: 16651734
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of a cloned pig intestinal peptide transporter (pPepT1).
Klang JE; Burnworth LA; Pan YX; Webb KE; Wong EA
J Anim Sci; 2005 Jan; 83(1):172-81. PubMed ID: 15583057
[TBL] [Abstract][Full Text] [Related]
8. Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells.
Balimane P; Sinko P
Biopharm Drug Dispos; 2000 Jul; 21(5):165-74. PubMed ID: 11180195
[TBL] [Abstract][Full Text] [Related]
9. Cancer cell-targeted drug delivery utilizing oligopeptide transport activity.
Nakanishi T; Tamai I; Takaki A; Tsuji A
Int J Cancer; 2000 Oct; 88(2):274-80. PubMed ID: 11004680
[TBL] [Abstract][Full Text] [Related]
10. Recognition of beta-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1 cells.
Terada T; Saito H; Mukai M; Inui K
Am J Physiol; 1997 Nov; 273(5):F706-11. PubMed ID: 9374833
[TBL] [Abstract][Full Text] [Related]
11. Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter.
Chu XY; Sánchez-Castaño GP; Higaki K; Oh DM; Hsu CP; Amidon GL
J Pharmacol Exp Ther; 2001 Nov; 299(2):575-82. PubMed ID: 11602669
[TBL] [Abstract][Full Text] [Related]
12. Membrane topology of the human dipeptide transporter, hPEPT1, determined by epitope insertions.
Covitz KM; Amidon GL; Sadée W
Biochemistry; 1998 Oct; 37(43):15214-21. PubMed ID: 9790685
[TBL] [Abstract][Full Text] [Related]
13. Evidence for overlapping substrate specificity between large neutral amino acid (LNAA) and dipeptide (hPEPT1) transporters for PD 158473, an NMDA antagonist.
Surendran N; Covitz KM; Han H; Sadee W; Oh DM; Amidon GL; Williamson RM; Bigge CF; Stewart BH
Pharm Res; 1999 Mar; 16(3):391-5. PubMed ID: 10213369
[TBL] [Abstract][Full Text] [Related]
14. A novel hPepT1 stably transfected cell line: establishing a correlation between expression and function.
Herrera-Ruiz D; Faria TN; Bhardwaj RK; Timoszyk J; Gudmundsson OS; Moench P; Wall DA; Smith RL; Knipp GT
Mol Pharm; 2004; 1(2):136-44. PubMed ID: 15832510
[TBL] [Abstract][Full Text] [Related]
15. Drug inhibition of Gly-Sar uptake and hPepT1 localization using hPepT1-GFP fusion protein.
Sun D; Landowski CP; Chu X; Wallsten R; Komorowski TE; Fleisher D; Amidon GL
AAPS PharmSci; 2001; 3(1):E2. PubMed ID: 11741253
[TBL] [Abstract][Full Text] [Related]
16. Hormonal regulation of dipeptide transporter (PepT1) in Caco-2 cells with normal and anoxia/reoxygenation management.
Sun BW; Zhao XC; Wang GJ; Li N; Li JS
World J Gastroenterol; 2003 Apr; 9(4):808-12. PubMed ID: 12679938
[TBL] [Abstract][Full Text] [Related]
17. Biophysical evidence for His57 as a proton-binding site in the mammalian intestinal transporter hPepT1.
Uchiyama T; Kulkarni AA; Davies DL; Lee VH
Pharm Res; 2003 Dec; 20(12):1911-6. PubMed ID: 14725353
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of a pH-sensing regulatory factor that modulates transport activity of the human H+/peptide cotransporter, PEPT1.
Saito H; Motohashi H; Mukai M; Inui K
Biochem Biophys Res Commun; 1997 Aug; 237(3):577-82. PubMed ID: 9299407
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants of the human dipeptide transporter PEPT1.
Anderle P; Nielsen CU; Pinsonneault J; Krog PL; Brodin B; Sadée W
J Pharmacol Exp Ther; 2006 Feb; 316(2):636-46. PubMed ID: 16258023
[TBL] [Abstract][Full Text] [Related]
20. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
